Shandong Buchang Pharmaceuticals Co., Ltd. (SHA:603858)
China · Delayed Price · Currency is CNY 15.91
-0.09 (-0.56%)
Aug 14, 2026, 3:00 PM CST
SHA:603858 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 11,669 | 11,875 | 11,006 | 13,245 | 14,951 | 15,763 |
Revenue Growth | 4.65% | 7.90% | -16.91% | -11.41% | -5.15% | -1.52% |
Gross Profit Gross Profit Growth | 7,108 | 7,195 | 6,454 | 8,924 | 10,683 | 11,629 |
Operating Income Operating Income Growth | 1,201 | 1,174 | 680.71 | 1,035 | 1,776 | 1,741 |
Net Income Net Income Growth | 373.94 | 360.78 | -553.8 | 318.97 | -1,530 | 1,289 |
Earnings Per Share EPS Growth | 0.35 | 0.34 | -0.51 | 0.29 | -1.38 | 1.17 |
EPS Growth | - | - | - | - | - | -30.72% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Pharmaceutical Divison Pharmaceutical Divison Growth | 10,659 |
Pharmaceutical Sales Pharmaceutical Sales Growth | 1,482 |
Other Operations Other Operations Growth | 790.94 |
Offset of Business Segment Offset of Business Segment Growth | -1,057 |
Total Total Growth | 11,875 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,869 | 1,258 | 1,223 | 1,048 | 2,875 | 1,716 |
Total Debt Total Debt Growth | 4,550 | 3,770 | 3,716 | 3,295 | 3,297 | 3,539 |
Net Cash (Debt) Net Cash Growth | -2,681 | -2,512 | -2,493 | -2,247 | -421.83 | -1,823 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -2.54 | -2.38 | -2.30 | -2.03 | -0.38 | -1.65 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 444.32 | 1,158 | 939.95 | -195.61 | 2,756 | 1,321 |
Capital Expenditures CapEx Growth | -102.55 | -123.42 | -197 | -529.92 | -543.17 | -433.53 |
Free Cash Flow Free Cash Flow Growth | 341.77 | 1,034 | 742.96 | -725.52 | 2,212 | 886.98 |
Free Cash Flow Growth | -75.53% | 39.22% | - | - | 149.44% | -37.64% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 60.91% | 60.59% | 58.64% | 67.38% | 71.45% | 73.77% |
Operating Margin | 10.29% | 9.89% | 6.19% | 7.82% | 11.88% | 11.04% |
Pretax Margin | 4.63% | 4.50% | -3.32% | 2.98% | -8.42% | 10.87% |
Profit Margin | 3.20% | 3.04% | -5.03% | 2.41% | -10.23% | 8.18% |
FCF Margin | 2.93% | 8.71% | 6.75% | -5.48% | 14.80% | 5.63% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.570 | 0.570 | - | 0.126 | 0.960 | 0.360 |
Dividend Per Share Growth | -53.85% | - | - | -86.88% | 166.67% | -31.56% |
Dividend Yield | 3.58% | 3.69% | - | 0.77% | 5.00% | 1.91% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 44.86 | 45.72 | - | 58.98 | - | 18.09 |
Forward PE | - | 25.13 | 25.13 | 25.13 | 25.13 | 25.13 |
P/FCF Ratio | 49.09 | 15.95 | 22.66 | - | 10.50 | 26.30 |
PS Ratio | 1.44 | 1.39 | 1.53 | 1.42 | 1.55 | 1.48 |